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Catheter directed thrombolysis has been described as a treatment for large pulmonary emboli resistant to systemic therapy [Kelly P,
Carroll N, Grant C, Barrett C, Kocka V. Successful treatment of massive pulmonary embolism with prolonged catheter-directed thrombolysis.
Heart Vessels 2006;21:124?6]. We now describe a case in which local catheter directed thrombolysis, via a peripherally inserted central
catheter (PICC), was used to treat a large thrombus surrounding the tip of an indwelling central venous line that was causing superior vena
cava obstruction (SVCO), in a patient with cystic fibrosis.
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A 34-year-old female with cystic fibrosis had a totally
implantable venous access device (TIVAD) (Groshong, Bard
Access Systems) sited in the left subclavian vein for long-
term intravenous therapy. The line was used for multiple
courses of intravenous antibiotics without complication for
2 years following insertion.
She presented to clinic complaining of distended neck
veins and facial discomfort on coughing. Examination
revealed facial and upper limb oedema and a fixed elevated
jugular venous pressure. On injecting through the central
venous catheter, flow was demonstrated but reduced. Urgent
venography visualised a large discrete thrombus occluding
the distal tip of the catheter and causing superior vena cava
obstruction (Fig. 1).
The patient was treated with a 10 mg bolus of intra-line
alteplase, followed by a 90 mg infusion over 2 h and subse-
quently with an unfractionated heparin infusion for a further? Corresponding author. Tel.: +44 1276 526660; fax: +44 1276 604032.
1569-1993/$ - see front matter ̀ 2007 European Cystic Fibrosis Society. Publishe
doi:10.1016/j.jcf.2007.02.00324 h at a rate of 1000 i.u./h. This improved her SVCO symp-
toms, however a repeat venogram showed no significantFig. 1. Initial venogram demonstrating a large thrombus occluding the tip of
the central venous catheter. The arrow indicates the site of the thrombus.
d by Elsevier B.V. All rights reserved.
Fig. 2. Final venogram showing complete resolution of the thrombus and the
presence of the second central venous catheter.
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heparin were repeated but again there was no resolution on
venography.
It was decided to use a novel approach whereby a periph-
erally inserted central catheter (PICC) was introduced via the
right basilic vein and its tip placed next to the thrombus within
the SVC. A continuous infusion of alteplase at 1 mg/h was
then administered for 7 days via the PICC. A final venogram
showed complete resolution of the thrombus (Fig. 2).
The TIVAD was removed and the patient discharged with
the PICC line in situ to continue intravenous antibiotics for a
concomitant chest infection.
2. Discussion
Indwelling intravenous catheters play an important role in
the long-term management of patients with cystic fibrosis.
They allow patients to have long-term intravenous antibiotic
courses and can facilitate blood sampling. Long-term venous
catheters are positioned so their tips lie within the superior
vena cava, aiding safe administration of systemic treatments
by causing less local venous inflammation.
The most common complications reported are line in-
fection and catheter occlusion with rates estimated at up to
21% a year [1]. Vascular thrombosis, as in this case, has a
reported frequency between 4.7% and 9% [1,2]. A single
discrete organised thrombus surrounding the catheter tip is
unusual with few descriptions in the literature.
In cases of thrombosis within catheter, the options to
manage this complication are essentially intra-line thrombo-
lysis or removal of the line. For intra-line thrombolysis, 2 mgof alteplase is injected into the occluded line and allowed to
dwell for 2 h. This can be repeated. The procedure has a
reported success rate of 74% [3]. Line removal is essentially a
fall-back position, usually when patency of the catheter is not
achieved.
In the case we describe, the central venous line was patent
but partially obstructed at its tip by thrombus enveloping the
catheter. This led to incomplete SVC obstruction. A full
thrombolysis regime, as used in treating pulmonary emboli, was
employed. This has been described as being beneficial in this
situation [4]. Since a large thrombolytic dosewas contemplated,
the potential for significant haemorrhagic complications was
discussed with the patient and informed consent obtained.
Intra-line alteplase infusions have been reported to dissolve
a large catheter-tip thrombus [5], but in our case it only
restored line patency at the tip and left a significant thrombus
around the distal catheter, despite repeated thrombolytic in-
fusions. The normal fall-back option of line removal was
considered hazardous as there was a substantial risk that the
thrombus would have been sheared off as the line was pulled
through the vein wall, potentially causing pulmonary emboli.
Warfarinisation was considered but deemed to be less
efficacious at clot resolution [6]. Catheter directed thrombo-
lysis provided a novel solution.
Due to the expanding use of centrally placed venous
catheters in all populations of patients, it is likely that the
prevalence of catheter-tip thrombus will increase. We would
encourage physicians to consider a catheter-directed ap-
proach as an alternative to intra-line therapy.
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